(Q39905290)

15 September 2017

title

Developing drugs to treat osteoporosis: lessons learned? (English)

1 reference

15 September 2017

0 references

1 reference

Francisco J A de Paula

series ordinal

1

1 reference

15 September 2017

Clifford J Rosen

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

Expert Opinion on Pharmacotherapy

15 September 2017

published in

1 reference

15 September 2017

volume

11

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

867-869

1 reference

Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903575662

Anti-vertebral fracture efficacy of raloxifene: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903575662

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903575662

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903575662

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903575662

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903575662

Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903575662

Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903575662

10.1517/14656560903575662

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference